Skip to content

Comparing Two Triamcinolone Injection Methods in Burn Scar

Comparative study of the effectiveness and pain of triamcinolone injection with microneedling and tuberculin needle in hypertrophic burn scars

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260318068999N1
Enrollment
54
Registered
2026-04-09
Start date
2026-05-05
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertrophic Scars of Burn Patients.

Interventions

Intervention 1: Intervention group (Microneedling): The dose of Triamcinolone (10 mg/mL) will be calculated based on the length and height of the scar and applied dropwise after the creation of microc

Sponsors

Gerash University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age range of 18 to 70 years presence of hypertrophic burn scars at least 8 weeks having passed since the burn injury having at least one wound with a minimum length of 4 centimeters willingness to provide written informed and voluntary consent.

Exclusion criteria

Exclusion criteria: Presence of an open wound active bleeding, or infection at the wound site pregnancy or breastfeeding wound located near the eyes or reproductive organs Inability to Attend for One-Month Follow-Up

Design outcomes

Primary

MeasureTime frame
Injection pain experience. Timepoint: Pain intensity will be measured only during the performance of each intervention method. Method of measurement: using the Observational Pain Scale in Intensive Care.;Wound redness. Timepoint: At the beginning of the study (before the start of the intervention) and one month after the completion of the intervention. Method of measurement: Using the Vancouver Scar Scale, which includes four main components: redness (vascularity), height, pliability, and pigmentation.;Wound height. Timepoint: At the beginning of the study (before the start of the intervention) and one month after the completion of the intervention. Method of measurement: Using the Vancouver Scar Scale, which includes four main components: redness (vascularity), height, pliability, and pigmentation.;Wound flexibility. Timepoint: At the beginning of the study (before the start of the intervention) and one month after the completion of the intervention. Method of measurement: Using the Vancouver Scar Scale, which includes four main components: redness (vascularity), height, pliability, and pigmentation.;Wound pigmentation. Timepoint: At the beginning of the study (before the start of the intervention) and one month after the completion of the intervention. Method of measurement: Using the Vancouver Scar Scale, which includes four main components: redness (vascularity), height, pliability, and pigmentation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdi Mohsenzadeh

Gerash University of Medical Sciences

mohsenmehdi@gmail.com+98 71 5244 8101

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026